DANAHER CORPORATION's ticker is DHR and the CUSIP is 235851102. A total of 1,767 filers reported holding DANAHER CORPORATION in Q4 2020. The put-call ratio across all filers is 0.97 and the average weighting 0.6%.
About DANAHER CORPORATION
Danaher Corporation is a global science and technology company that designs, manufactures, and markets innovative products and services to professional, medical, industrial, and commercial customers. The company operates through four segments: Life Sciences, Diagnostics, Dental, and Environmental & Applied Solutions.
Danaher's Life Sciences segment provides a range of research tools to scientists around the world, including mass spectrometry, chromatography, and automation systems. The Diagnostics segment offers a broad range of diagnostic products, including clinical chemistry, immunoassay, microbiology, and molecular diagnostic systems. The Dental segment provides a range of dental equipment and consumables, including imaging systems, dental instruments, and consumables. The Environmental & Applied Solutions segment offers a range of products and services to help customers protect the environment and improve productivity.
Danaher has a strong track record of growth and innovation, driven by its focus on continuous improvement and customer satisfaction. The company has a culture of operational excellence, which has enabled it to consistently deliver high-quality products and services to its customers. Danaher's management team is highly experienced and has a proven track record of creating value for shareholders.
In conclusion, Danaher Corporation is a well-established and innovative company that is well-positioned to continue delivering strong growth and value to its shareholders. With its focus on operational excellence and customer satisfaction, Danaher is a company that investors should keep an eye on.
It's important to note that this information is for educational purposes only and has not been fact-checked. As with any investment, it's important to do your own research and consult with a financial advisor before making any investment decisions.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $21,063,251 | +9.5% | 84,899 | +5.9% | 0.48% | +8.7% |
| Q2 2023 | $19,233,259 | +2.0% | 80,139 | +7.1% | 0.45% | -6.9% |
| Q1 2023 | $18,860,398 | -4.9% | 74,832 | +0.1% | 0.48% | -14.2% |
| Q4 2022 | $19,839,083 | +3.9% | 74,746 | +1.1% | 0.56% | -14.3% |
| Q3 2022 | $19,095,000 | -0.1% | 73,927 | -1.9% | 0.65% | -13.5% |
| Q2 2022 | $19,107,000 | -20.6% | 75,367 | -8.1% | 0.75% | -15.9% |
| Q1 2022 | $24,053,000 | -8.8% | 82,001 | +2.2% | 0.90% | -13.3% |
| Q4 2021 | $26,386,000 | +13.6% | 80,197 | +5.1% | 1.03% | -6.1% |
| Q3 2021 | $23,221,000 | -0.7% | 76,273 | -12.5% | 1.10% | -14.7% |
| Q2 2021 | $23,385,000 | +21.2% | 87,140 | +1.7% | 1.29% | +6.0% |
| Q1 2021 | $19,294,000 | +27.1% | 85,720 | +25.4% | 1.22% | +10.5% |
| Q4 2020 | $15,183,000 | +29.0% | 68,350 | +25.0% | 1.10% | -10.7% |
| Q3 2020 | $11,770,000 | +21.6% | 54,660 | -0.2% | 1.23% | +7.6% |
| Q2 2020 | $9,683,000 | +15.2% | 54,754 | -9.8% | 1.14% | -5.9% |
| Q1 2020 | $8,405,000 | -9.8% | 60,724 | 0.0% | 1.22% | +6.9% |
| Q4 2019 | $9,319,000 | +23.9% | 60,724 | +16.6% | 1.14% | -0.3% |
| Q3 2019 | $7,521,000 | +1.2% | 52,074 | +0.2% | 1.14% | -5.3% |
| Q2 2019 | $7,429,000 | +12.2% | 51,980 | +3.6% | 1.20% | +6.9% |
| Q1 2019 | $6,622,000 | +26.8% | 50,160 | -1.0% | 1.13% | +5.5% |
| Q4 2018 | $5,224,000 | -29.7% | 50,660 | -25.9% | 1.07% | -20.5% |
| Q3 2018 | $7,428,000 | +10.1% | 68,360 | 0.0% | 1.34% | +1.6% |
| Q2 2018 | $6,746,000 | +19.5% | 68,360 | +18.5% | 1.32% | +6.6% |
| Q1 2018 | $5,647,000 | +10.3% | 57,680 | +4.6% | 1.24% | +15.3% |
| Q4 2017 | $5,119,000 | +31.0% | 55,150 | +21.1% | 1.08% | +31.3% |
| Q3 2017 | $3,907,000 | +20.0% | 45,550 | +18.1% | 0.82% | +18.9% |
| Q2 2017 | $3,255,000 | +14.7% | 38,570 | +16.2% | 0.69% | +8.8% |
| Q1 2017 | $2,839,000 | +24.0% | 33,190 | +12.9% | 0.63% | +15.1% |
| Q4 2016 | $2,289,000 | +10.3% | 29,410 | +11.1% | 0.55% | +5.4% |
| Q3 2016 | $2,075,000 | -22.4% | 26,470 | 0.0% | 0.52% | -28.8% |
| Q2 2016 | $2,673,000 | +6.5% | 26,470 | 0.0% | 0.73% | -4.1% |
| Q1 2016 | $2,511,000 | +16.8% | 26,470 | +14.3% | 0.76% | -13.2% |
| Q4 2015 | $2,150,000 | +10.8% | 23,150 | +1.6% | 0.88% | -2.8% |
| Q3 2015 | $1,941,000 | +17.1% | 22,780 | +17.6% | 0.90% | +41.8% |
| Q2 2015 | $1,658,000 | +14.5% | 19,370 | +13.5% | 0.64% | -5.9% |
| Q1 2015 | $1,448,000 | +59.5% | 17,060 | +61.1% | 0.68% | +51.3% |
| Q4 2014 | $908,000 | – | 10,590 | – | 0.45% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| RobecoSam USA, Inc. | 74,961 | $7,572,000 | 9.43% |
| Corvid Peak Capital Management, LLC | 250,000 | $25,250,000 | 8.54% |
| CORTLAND ASSOCIATES INC/MO | 310,508 | $31,361,000 | 6.88% |
| Southpoint Capital Advisors LP | 1,250,000 | $126,250,000 | 6.75% |
| GREEN VALLEY INVESTORS LLC | 2,168,594 | $219,027,000 | 6.70% |
| DAVIS-REA LTD. | 75,080 | $7,595,000 | 5.39% |
| CADINHA & CO LLC | 247,143 | $24,961,000 | 5.35% |
| Espalier Global Management LLC | 47,100 | $4,757,000 | 5.25% |
| Spears Abacus Advisors LLC | 398,334 | $40,232,000 | 5.10% |
| GCA INVESTMENT MANAGEMENT, LLC | 158,064 | $15,964,000 | 5.01% |